Showing results (311-320 of 468) with videos related to

Sort By:
Pageof 47
Journal of Hepatology|February 2, 2016
Assessment of response to beta-blockers by expression of βArr2 and RhoA/ROCK2 in antrum mucosa in cirrhotic patientsJonel Trebicka, Matthias von Heydebrand, Jennifer Lehmann, et al.
Digestive Diseases and Sciences|March 18, 2022
Covered Transjugular Intrahepatic Portosystemic Shunt Improves Hypersplenism-Associated Cytopenia in CirrhosisTheresa Bucsics, Katharina Lampichler, Constantin Vierziger, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|February 5, 2020
Epidemiological trends in HCV transmission and prevalence in the Viennese HIV+ populationCaroline Schmidbauer, David Chromy, Victor Schmidbauer, et al.
Journal of Viral Hepatitis|September 5, 2022
HCV hotline facilitates Hepatitis C elimination during the COVID-19 pandemicLukas Hartl, Mathias Jachs, David Bauer, et al.
Gastrointestinal Endoscopy|May 5, 2025
Improved clinical outcomes of patients with cirrhosis and acute variceal bleeding over the last 2 decadesNikolaus Pfisterer, Florian Riedl, Michael Schwarz, et al.
Hepatology (Baltimore, Md.)|November 16, 2017
Perioperative von Willebrand factor dynamics are associated with liver regeneration and predict outcome after liver resectionPatrick Starlinger, David Pereyra, Stefanie Haegele, et al.
Journal of Thrombosis and Haemostasis : JTH|August 10, 2024
Anticoagulation for splanchnic vein thrombosis in myeloproliferative neoplasms: a systematic review and meta-analysisPavlina Chrysafi, Kevin Barnum, Genevieve M Gerhard, et al.
Journal of Clinical Medicine|November 28, 2018
De-Ritis Ratio Improves Long-Term Risk Prediction after Acute Myocardial InfarctionMatthias Steininger, Max-Paul Winter, Thomas Reiberger, et al.
Journal of Hepatology|February 18, 2014
Pioglitazone decreases portosystemic shunting by modulating inflammation and angiogenesis in cirrhotic and non-cirrhotic portal hypertensive ratsPhilipp Schwabl, Berit A Payer, Jelena Grahovac, et al.
Wiener Klinische Wochenschrift|June 20, 2018
Anticoagulation in non-malignant portal vein thrombosis is safe and improves hepatic functionBernhard Scheiner, Paul René Stammet, Sebastian Pokorny, et al.
Pageof 47